Rubicon Organics Secures R&D License from Health Canada newcannabisventures.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newcannabisventures.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ THC is perhaps the most well-known cannabinoid within cannabis. THC, short for tetrahydrocannabinol, is famously responsible for cannabis s.
Full Spectrum Cannabis Products Industry Expected To Remain Robust Through 2027 Financialnewsmedia.com News Commentary PALM BEACH, Fla., April 8, 2021 /PRNewswire/ Cannabis extracts have gained wide recognition in recent years and are expected to provide impetus to cannabis market growth. Based on product type, cannabis extracts are classified into oils and tinctures. Growing legalization of cannabis in various countries, preference for cannabis oil and tinctures, and adoption of medical marijuana for treating chronic diseases like arthritis, anxiety, and Alzheimer s are the major factors propelling the growth. According to a report from Grand View, the oils segment is expected to dominate the market and is anticipated to witness the fastest CAGR of 17.5%, through 2027. The report added that the global cannabis extract market size is expected to be valued at US $28.5 billion by 2027, and it is projected to expand at a CAGR of 16.6% through 2027 also. Other key findings of the report are that: In 2019, oils held the largest revenue share of 66.5% owing to ease of availability and low price of the product; The full spectrum segment was valued at USD 4.3 billion in 2019, owing to its entourage effect-a synergistic relationship between cannabinoids and terpenes that exhibits an increase in the healing properties of each cannabinoid. Active companies in news today include
(Image: Evie Fjord on Unsplash) Moncton-based medical and recreational cannabis producer Organigram is looking to strengthen its position in the growing edibles market with its new acquisition. Organigram Holdings Inc., the parent company of Organigram Inc. has announced it has acquired all of the issued and outstanding shares of The Edibles & Infusions Corporation (EIC) for consideration of $22-million, plus up to an additional $13-million in shares payable upon the EIC business achieving certain earnout milestones. The EIC acquisition will broaden Organigram’s edible product offerings and provides an operational footprint in Western Canada. EIC was co-founded by AgraFlora Organics International Inc. and James Fletcher, who is the CEO of Cavalier Candies, one of Canada’s oldest confectionery companies. EIC constructed a purpose-built, highly-automated, 51,000-square-foot manufacturing facility located in Winnipeg, Manitoba.
InterVivo Solutions Issued Institutional Cannabis Research License by Health Canada Toronto, Ontario (Newsfile Corp. - February 4, 2021) - InterVivo Solutions Inc. ( InterVivo or the Company ), a leading Canadian contract research organization providing preclinical in vivo research services that enable the pharmaceutical and nutraceutical industries to develop new products and therapies for neuropsychiatric and neurological diseases, is pleased to announce that it has been issued an Institution-wide Research License from Health Canada under the Cannabis Act and Cannabis Regulations. The Institution-wide Research License (IRL) enables InterVivo to conduct multiple studies across all departments at its research facility without the need to apply for study-specific research licenses. Essentially, InterVivo is now granted broad approval to research and develop all cannabis-based products across all of its translational drug discovery services. InterVivo s clients will benefit with reduced costs, greater study flexibility and shorter turnaround times for their cannabis research & development projects. The IRL will also provide the opportunity to run comparative studies against gold standard cannabinoids such as THC and CBD, as well as interrogate how these classic cannabinoids affect the brain and body.